Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Internal Medicine

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2796.2006.01617.xPMID 16476109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long‐Term Safety and Efficacy of Circumferential Ablation with Pulmonary Vein Isolation

  2006cited by this paper
• The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003

  2005cited by this paper
• Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.

  2005cited by this paper
• Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes--data from the National Diabetes Register in Sweden.

  2004cited by this paper
• Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop.

  2004cited by this paper
• Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.

  2004cited by this paper
• The role of fibrates in managing hyperlipidemia: Mechanisms of action and clinical efficacy

  2004cited by this paper
• IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.

  2004cited by this paper
• Type 2 diabetes in the young: the evolving epidemic.

  2004cited by this paper
• [Obesity and diabetes mellitus].

  2004cited by this paper
• The kidney, hypertension, and obesity.

  2003cited by this paper
• Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden

  2003cited by this paper
• The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care.

  2003cited by this paper
• New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism

  2002cited by this paper
• PREVEND STUDY GROUP OBESITY AND TARGET ORGAN DAMAGE: THE KIDNEY

  2002cited by this paper
• Obesity and target organ damage: the kidney

  2002cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2000.

  2002cited by this paper
• Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold.

  2001cited by this paper
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

  2000cited by this paper
• Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

  2000cited by this paper
• Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

  1999cited by this paper
• The spread of the obesity epidemic in the United States, 1991-1998.

  1999cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Gender, Autoantibodies, and Obesity in Newly Diagnosed Diabetic Patients Aged 40–75 Years

  1998cited by this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cited by this paper
• Triglyceride: the forgotten risk factor.

  1998cited by this paper
• Triglyceride as a risk factor for coronary artery disease.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cited by this paper
• Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Triglyceride: the forgotten risk factor.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

  1997cited by this paper
• patients with type II diabetes mellitus

  1997cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Insulin resistance in insulin-dependent diabetic patients with microalbuminuria.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Treatment of hypertension in diabetes.

  1993cited by this paper
• Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria.

  1993cited by this paper
• Combination therapy in NIDDM.

  1992cited by this paper
• One‐year response to evening insulin therapy in non‐insulin‐dependent diabetes

  1992cited by this paper
• Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• Evidence for an independent relationship between insulin resistance and fasting plasma HDL‐cholesterol, triglyceride and insulin concentrations

  1992cited by this paper
• Diabetes Care and Research in Europe: The Saint Vincent Declaration

  1990cited by this paper
• Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes

  1989cited by this paper
• Obesity and diabetes mellitus.

  1974cited by this paper
• THE KIDNEY

  1951cited by this paper

• High Glycemic Variability as a Risk Factor for CKD Progression in Type 2 Diabetes with Mild-to-Moderate Kidney Dysfunction

  2025cites this paper
• Determinants of Hypertension Among Women with Type 2 Diabetes Attending Urban Primary Healthcare Centers in Inezgane and Agadir, Southern Morocco: A Cross-Sectional Study

  2025cites this paper
• Glipizide has Low Influences on Lipid Index and Major Organs Weight Variation and Considerable Anxiolytic Properties: An in vivo Investigation

  2023cites this paper
• Metabolically ‘extremely unhealthy’ obese and non-obese patients with diabetes and the risk of cardiovascular events: a French nationwide cohort study

  2023cites this paper
• Weight Loss Interventions and Skeletal Health in Persons with Diabetes

  2022cites this paper
• Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank

  2022influential citation
• Comparing Associations of Dietary Energy Density and Energy Intake, Macronutrients with Obesity in Patients with Type 2 Diabetes (JDDM 63)

  2021cites this paper
• Waist-to-height ratio has a stronger association with cardiovascular risks than waist circumference, waist-hip ratio and body mass index in type 2 diabetes.

  2021cites this paper
• Trends in diabetes medication use in Australia, Canada, England, and Scotland: a repeated cross-sectional analysis in primary care

  2020cites this paper
• Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity.

  2020cites this paper
• Obesity and cardiovascular disease in women

  2020cites this paper
• Weight Loss as an Integral Part of Obesity & Metabolic Syndrome Management

  2019cites this paper
• Association of Obesity Indicators with Hypertension in Type 2 Diabetes Mellitus Patients

  2019cites this paper
• Safety, tolerability and efficacy of a novel self‐use biodegradable device for management of obesity

  2019cites this paper
• Cardiovascular Disease in Type 2 Diabetes: A Review of Sex‐Related Differences in Predisposition and Prevention

  2019cites this paper
• Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at St. Paul’s Hospital, Addis Ababa, Ethiopia

  2018cites this paper
• Indices in Pregnant Streptozotocin-Induced Diabetic Rats Treated with Gliclazide and Insulin

  2018cites this paper
• Obesity and bariatric surgery in Sweden. Sociodemographic aspects and neighbourhood deprivation.

  2018cites this paper
• Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

  2018cites this paper
• Weight Loss and Weight Loss Maintenance in Type 2 Diabetes

  2017cites this paper
• Latent class analysis suggests four classes of persons with type 2 diabetes mellitus based on complications and comorbidities in Tianjin, China: a cross-sectional analysis.

  2017cites this paper
• Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.

  2017cites this paper
• Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects.

  2017cites this paper
• Investigation on the relationship between cholesterol and blood glucose levels using decision tree method in healthy subjects

  2017cites this paper
• Cost-effectiveness of insulin detemir compared with NPH insulin in people with type 2 diabetes in Denmark , Finland , Norway , and Sweden

  2017cites this paper
• Comparison of health- related quality of life between obese women with binge eating disorder and obese women without binge eating disorder

  2017cites this paper
• Associations between metabolic disorders and risk of cancer in Danish men and women – a nationwide cohort study

  2016cites this paper
• Combination therapy of SGLT2 inhibitors with incretin-based therapies for the treatment of type 2 diabetes mellitus: Effects and mechanisms of action

  2016cites this paper
• Aalborg Universitet Associations between metabolic disorders and risk of cancer in Danish men and women a nationwide cohort study

  2016cites this paper
• Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.

  2016cites this paper
• Syddansk Universitet Associations between metabolic disorders and risk of cancer in Danish men and women a nationwide cohort study

  2016cites this paper
• Traditional Chinese Medicine for Metabolic Syndrome via TCM Pattern Differentiation: Tongue Diagnosis for Predictor

  2016cites this paper
• Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study

  2016cites this paper
• Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class

  2016cites this paper
• Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?

  2016cites this paper
• Trends in Anthropometric Indexes, Blood Pressure, Smoking and Lipids Over a Decade in Diabetic and Non-Diabetic Populations: Tehran Lipid and Glucose Study

  2015cites this paper
• EFFICACY OF COGNITIVE-BEHAVIORAL INTERVENTIONS IN WEIGHT LOSS OF PEOPLE WITH BODY MASS INDEX OF 30 OR ABOVE (OBESITY)

  2015cites this paper
• Prevalence of Hypertension and Obesity among Emirati Patients with Type 2 Diabetes

  2015cites this paper
• Diabetic Mellitus as Risk Factor Cardiovascular Disease in Province of Diyala

  2015cites this paper
• Characterization of Patients with Type 2 Diabetes according to Body Mass Index: Korea National Health and Nutrition Examination Survey from 2007 to 2011

  2015cites this paper
• Weight Gain on Glucose-Lowering Agents

  2014cites this paper
• The importance of weight management in type 2 diabetes mellitus

  2014cites this paper
• Association of Changes in Body Composition with Changes in Systemic Oxidative Stress Following Weight Loss Program in Obese Adults Attending Obesity Clinic, Hospital Universiti Sains Malaysia

  2014cites this paper
• Trends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study

  2014cites this paper
• The triglycerides-to-HDL-cholesterol ratio and cardiovascular disease risk in obese patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).

  2014cites this paper
• Association between major non-communicable diseases risk factors and fasting blood glucose in Iran: comparison of two techniques, with and without dichotomizing the response.

  2014cites this paper
• Regimes terapêuticos e controlo glicémico nos diabéticos tipo 2 de uma unidade de saúde familiar

  2014cites this paper
• Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register

  2013cites this paper
• The Effects of Gliclazide, Metformin, and Acarbose on Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

  2013cites this paper
• Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T‐emerge 7 study)

  2013cites this paper
• ŧŐţǀź ƪưĪƯ ƿŹŚƽ L ƳŹŚĩǀŤǀƲ ŚƤƯ Źŵƿƶƀ Śŝ źưţƿƲ ŻřƺƷƽ ƎsƺŤƯ źŝ ƫƺƀƳř ƶŝ ŢƯƹŚƤƯǀ Ʋƹ ƆųŚƃ ŚƷƽƲţ Ŭƴsƾ Źŵ ƱŚƳŻ ơŚģ źŤƧŵźƯƿƝŹ ƝŹ

  2013cites this paper
• Profile Of Cardiovascular Disease Risk Factors In Normoalbuminuric Nigerian Diabetic Patients.

  2013cites this paper
• Original article Cost-effectiveness of insulin detemir compared withNPHinsulininpeoplewithtype2diabetes in Denmark, Finland, Norway, and Sweden

  2013cites this paper
• Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review

  2013cites this paper
• Intra-Renal Inflammation in Obesity and Type 2 Diabetes Mellitus

  2013cites this paper
• Trends in cardiovascular risk factors among people with diabetes in a population based study, Health Survey for England 1994-2009.

  2013cites this paper
• Cost-effectiveness of insulin detemir compared with NPH insulin in people with type 2 diabetes in Denmark, Finland, Norway, and Sweden

  2013cites this paper
• Change in Lifestyle through Health Promotion Program without Face‐to‐Face Intervention in a Large‐scale Japanese Enterprise

  2013cites this paper
• Differentiating among incretin therapies: a multiple‐target approach to type 2 diabetes

  2012cites this paper
• Sympathetic nerve activity in women 40 years after a hypertensive pregnancy

  2012cites this paper
• Levnadsvanor, upplevd stress och bälsa hos personal inom ambulansens och räddningstjänstens verksamheter

  2012cites this paper
• Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors.

  2012cites this paper
• RelaciÛn entre caracterÌsticas antropomÈtricas y variables de riesgo vascular en diabÈticos tipo 2 Relationship between anthropometric characteristics and its repercussion i n Type -2 Diabetes Mellitus

  2012cites this paper
• Relationship between anthropometric characteristics and its repercussion in Type-2 Diabetes Mellitus

  2012influential citation
• تأثیر مکمل یاری L-کارنیتین در مقایسه با تمرین هوازی متوسط بر مقاومت به انسولین و شاخصهای تنسنجی در زنان چاق

  2012cites this paper
• Weight gain associated with antidiabetic medications

  2011cites this paper
• Outcomes of Lifestyle Improvement Programs in the Last Ten Years in Asia

  2011cites this paper
• Diabetes and obesity in primary health care - a condition beyond physiological factors

  2011cites this paper
• Cardiovaskular risk factors and complications in type 1 and type 2 diabetes

  2010cites this paper
• Type 2 diabetes: assessing the relative risks and benefits of glucose-lowering medications.

  2010cites this paper
• Evolving Pandemic Diabetic Nephropathy

  2010cites this paper
• Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database

  2010cites this paper
• Factors affecting metformin plasma concentrations

  2010cites this paper
• New Perspectives in Type 2 Diabetes, Cardiovascular Risk, and Treatment Goals

  2010cites this paper
• Stabilité des caractéristiques de sujets métaboliquement obèses de poids normal (MONW) dans une cohorte de jeunes femmes sur une période d'un an

  2009cites this paper
• Antidiabetic medications and weight gain: Implications for the practicing physician

  2009cites this paper
• Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR)

  2009cites this paper
• Tratamiento intensivo multifactorial de la diabetes Mellitus tipo 2

  2009cites this paper
• 2 diabetes: a large prospective study in Ukraine type cardiovascular mortality among patients with Body mass index and the risk of total and

  2009cites this paper
• Gender: does it have a role in blood pressure in Caucasians with well-controlled type 2 diabetes?

  2009cites this paper
• Dual source computed tomography with delayed imaging for left atrial appendage thrombus compared with transoesophageal echocardiography

  2009cites this paper
• Fifteen-month lifestyle intervention program to improve cardiovascular risk factors in a community population in Japan.

  2009cites this paper
• Diabetes and obesity in older adults: a call to action

  2009cites this paper
• Metformin and body weight

  2008cites this paper
• Struck by ACCORD

  2008cites this paper
• Switching basal analogue insulins - short-term weight effects

  2008cites this paper
• Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.

  2008cites this paper
• An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update)

  2008cites this paper
• Obesity and intermediate clinical outcomes in diabetes: evidence of a differential relationship across ethnic groups

  2008cites this paper
• Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients

  2008cites this paper
• Factors of cardiovascular risk in patients with type 2 diabetes and incipient nephropathy.

  2008cites this paper
• Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease

  2008cites this paper
• Insulin Analogs: Impact on Treatment Success, Satisfaction, Quality of Life, and Adherence

  2008cites this paper
• Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine

  2008cites this paper
• Is there really good news about pandemic diabetic nephropathy?

  2007cites this paper
• Bodyweight Changes Associated with Antihyperglycaemic Agents in Type 2 Diabetes Mellitus

  2007cites this paper
• Relationship between lifestyle and change of cardiovascular risk factors based on a five-year follow-up of employees in Japan.

  2007cites this paper
• PREDICTIVE™– a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort

  2007cites this paper
• Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.

  2007cites this paper
• Insulin Detemir Results in Less Weight Gain than NPH Insulin When Used in Basal-Bolus Therapy for Type 2 Diabetes Mellitus, and this Advantage Increases with Baseline Body Mass Index

  2007cites this paper